Atlazo Announces Plans to Launch Health-System-on-Chip™ for Intelligent Body-Worn Devices and IoMT

Wednesday, October 31, 2018 Medical Gadgets
Email Print This Page Comment bookmark
Font : A-A+

Medical device industry veteran Adnan Shennib appointed President of Life Sciences

SAN DIEGO, Oct. 31, 2018 /PRNewswire-PRWeb/ -- Atlazo Inc, the leader in semiconductors for intelligent healthcare, announced

today plans to launch the first Healthcare-System-on-Chip (HSoC) for applications in wearables and implants. Atlazo's healthcare-focused semiconductors bring cutting edge innovations in machine learning, ultra-low power semiconductor technology, and wireless connectivity into single chip solutions.The highly integrated platform will offer device manufactures unprecedented computational power for on-device Artificial Intelligence (AI) and Machine Learning (ML), dramatically reducing cost and time-to-market for next generation healthcare products, while improving clinical outcomes and quality of care.

The company also announced the appointment of Adnan Shennib as President of Life Sciences to lead Atlazo's healthcare product and business development. Shennib brings over 30 years of experience in healthcare innovations, starting his career in implantable cardiac pacing, and later taking leading roles with several hearing aid manufacturers including ReSound, InSound Medical where he invented and developed the Lyric™ hearing device, and more recently founding iHEAR Medical where he led the development and launch of the first FDA-cleared hearing solutions for direct-to-consumer and OTC markets. Shennib holds over 100 patents in medical devices and hearing devices, a B.S. in Electrical and Computer Engineering from the University of California, Santa Barbara, and an M.S. in Biomedical Engineering from the University of Texas. Shennib will continue to support iHEAR Medical as its founder and member of the board of directors.

"I am excited to join Atlazo to bring its novel semiconductor architecture to the rapidly growing smart wearable and implant markets. Atlazo's healthcare-focused semiconductor technology will not only transform legacy products to incorporate wireless connectivity and machine learning, but also create new types of devices for disease management, prevention, health tracking and more advanced hearing and therapeutic devices," stated Shennib.

Under Shennib's leadership, the company will expand partnerships with manufacturers of innovative wearables, hearing devices, and implants, as well as semiconductor manufacturers, distributors, and researchers seeking medical-grade personal healthcare data.

NOVEL SEMICONDUCTOR ARCHITECTURE FOR IoMT Atlazo's healthcare-focused semiconductors, with embedded wireless connectivity and machine learning, provide backbone for the Internet of Medical Things (IoMT), keeping people safe and healthy by notifying healthcare providers with relevant data and identifying health issues before they become critical and allowing for early intervention.

For more information on partnership or distribution opportunities, please contact partner(at)

ABOUT ATLAZO Atlazo is the leader in semiconductors and machine learning for intelligent healthcare, targeting the exponentially growing wearable and implant markets. Founded in 2016 and headquartered in San Diego, CA, the company is dedicated to addressing the global demand for more cost-effective and accessible healthcare, and to bridging the gap between cloud and edge computing in healthcare. Atlzao's Healthcare-System-on-Chip™ (HSoC) offers manufacturers a platform for rapid development of innovative body-worn healthcare products, dramatically reducing costs and time-to-market, while improving clinical outcomes and quality of care. Atlazo brings cutting edge innovations in ultra-low power semiconductor technology, a neural processing, wireless connectivity, and biosensing for IoMT and healthcare AI applications. Atlazo is a member company of EvoNexus, California's leading incubator of technology startups.

For more information on Atlazo, visit:



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store